# Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure

> **NCT00077948** · PHASE3 · TERMINATED · sponsor: **Gilead Sciences** · enrollment: 175 (—)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **DRUG:** Enoximone
- **DRUG:** Metoprolol succinate
- **DRUG:** Placebo to match enoximone
- **DRUG:** Placebo to match metoprolol succinate

## Key facts

- **NCT ID:** NCT00077948
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-07
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 175 (—)
- **Last updated:** 2014-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00077948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00077948, "Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00077948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*